Tag results:

lymphoid cells

Cancer Drivers and Clonal Dynamics in Acute Lymphoblastic Leukemia Subtypes

[Blood Cancer Journal] To obtain a comprehensive picture of composite genetic driver events and clonal dynamics in subtypes of pediatric acute lymphoblastic leukemia, scientists analyzed tumor-normal whole genome sequencing and expression data from 361 newly diagnosed patients.

Long-Term Survival with Mixed Chimerism in Patients with AML and MDS Transplanted after Conditioning with Targeted Busulfan, Fludarabine, and Thymoglobulin

[Bone Marrow Transplantation] The authors evaluated long-term outcome in 40 patients with myelodysplastic syndrome or acute myeloid leukemia, transplanted from related or unrelated donors following conditioning with targeted busulfan, fludarabine, and thymoglobulin.

Rare t(X; 14)(q28; q32) Translocation Reveals Link between MTCP1 and Chronic Lymphocytic Leukemia

[Nature Communications] Scientists reported overexpression of human mature T cell proliferation 1 gene (MTCP1) restricted to the B cell compartment in mice produced a clonal CD5+/CD19+ leukemia recapitulating the major characteristics of human chronic lymphocytic leukemia.

Carbon Ion Radiotherapy Boosts Anti-Tumour Immune Responses by Inhibiting Myeloid-Derived Suppressor Cells in Melanoma-Bearing Mice

[Cell Death Discovery] The abundance of myeloid-derived suppressor cells in the tumour microenvironment was associated with therapeutic efficacy and disease outcome. Scientists analyzed the changes in the immune contexture in response to the carbon ion treatment.

piggyBac System to Co-Express NKG2D CAR and IL-15 to Augment the In Vivo Persistence and Anti-AML Activity of Human Peripheral Blood NK Cells

[Molecular Therapy-Methods & Clinical Development] Using a non-viral piggyBac transposon technology and human peripheral blood derived primary natural killer (NK) cells, scientists generated CAR-NK cells to target NKG2D ligands.

Demethylating Therapy Increases Anti-CD123 CAR T Cell Cytotoxicity against Acute Myeloid Leukemia

[Nature Communications] The authors developed third-generation anti-CD123 CAR T cells with a humanized CSL362-based ScFv and a CD28-OX40-CD3ζ intracellular signaling domain.

Popular